323 related articles for article (PubMed ID: 18046234)
1. Quantification of sedimented triamcinolone for intravitreal injection.
Tsong JW; Persaud TO; Mansour SE
Retina; 2007; 27(9):1255-9. PubMed ID: 18046234
[TBL] [Abstract][Full Text] [Related]
2. Concentrating method for intravitreal triamcinolone acetonide injection.
Hernaez-Ortega MC; Soto-Pedre E
Retina; 2008; 28(7):1023; author reply 1023. PubMed ID: 18698311
[No Abstract] [Full Text] [Related]
3. Intravitreal triamcinolone acetonide concentration after subtenon injection.
Thomas ER; Wang J; Ege E; Madsen R; Hainsworth DP
Am J Ophthalmol; 2006 Nov; 142(5):860-1. PubMed ID: 17056371
[TBL] [Abstract][Full Text] [Related]
4. Intraocular concentration of triamcinolone acetonide after intravitreal injection in the rabbit eye.
Kamppeter BA; Cej A; Jonas JB
Ophthalmology; 2008 Aug; 115(8):1372-5. PubMed ID: 18355920
[TBL] [Abstract][Full Text] [Related]
5. Measurement of the actual dose of triamcinolone acetonide delivered by common techniques of intravitreal injection.
Ober MD; Barile GR; Tari SR; Tosi GM; Schiff WM; Chang S
Am J Ophthalmol; 2006 Oct; 142(4):597-600. PubMed ID: 17011851
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal triamcinolone acetonide injection at the end of vitrectomy for diabetic vitreous hemorrhage: a randomized, clinical trial.
Faghihi H; Taheri A; Farahvash MS; Esfahani MR; Rajabi MT
Retina; 2008 Oct; 28(9):1241-6. PubMed ID: 18626423
[TBL] [Abstract][Full Text] [Related]
7. A simple and rapid method for purification of triamcinolone acetonide suspension for intravitreal injection.
Hernaez-Ortega MC; Soto-Pedre E
Ophthalmic Surg Lasers Imaging; 2004; 35(4):350-1. PubMed ID: 15305565
[TBL] [Abstract][Full Text] [Related]
8. Short-term intraocular pressure trends after intravitreal triamcinolone injection.
Lee EW; Hariprasad SM; Mieler WF; Newman TL; Apte RS
Am J Ophthalmol; 2007 Feb; 143(2):365-7. PubMed ID: 17258540
[TBL] [Abstract][Full Text] [Related]
9. Triamcinolone acetonide concentration of aqueous humor after decanted 20-mg intravitreal injection.
Cheng L; Banker AS; Martin M; Kozak I; Freeman WR
Ophthalmology; 2009 Jul; 116(7):1356-9. PubMed ID: 19450879
[TBL] [Abstract][Full Text] [Related]
10. Carboxymethylcellulose as a new carrier substance for intravitreal injection of reproducible amounts of triamcinolone.
Kube T; Sutter M; Trittler R; Feltgen N; Hansen LL; Agostini HT
Graefes Arch Clin Exp Ophthalmol; 2006 Nov; 244(11):1385-90. PubMed ID: 16715253
[TBL] [Abstract][Full Text] [Related]
11. Removal of benzyl alcohol from a commercially available triamcinolone acetonide suspension for intravitreal use.
Hernaez-Ortega MC; Soto-Pedre E
Ophthalmic Surg Lasers Imaging; 2006; 37(2):162-4. PubMed ID: 16583642
[TBL] [Abstract][Full Text] [Related]
12. A prospective study of early intraocular pressure changes after a single intravitreal triamcinolone injection.
Im L; Allingham RR; Singh I; Stinnett S; Fekrat S
J Glaucoma; 2008 Mar; 17(2):128-32. PubMed ID: 18344759
[TBL] [Abstract][Full Text] [Related]
13. Anatomic and visual outcomes of noninfectious endophthalmitis after intravitreal triamcinolone.
Yoon SJ; Rhee DY; Marx JL; Blaha GR; Rogers AH; Baumal CR; Reichel E; Duker JS
Am J Ophthalmol; 2009 Jun; 147(6):1031-6. PubMed ID: 19268893
[TBL] [Abstract][Full Text] [Related]
14. Effects of repeated injection of intravitreal triamcinolone on macular oedema in central retinal vein occlusion.
Wang L; Song H
Acta Ophthalmol; 2009 May; 87(3):285-9. PubMed ID: 18507724
[TBL] [Abstract][Full Text] [Related]
15. Visualization of residual perfluorocarbon liquid using intravitreal triamcinolone acetonide.
Hirata F; Tamura H; Ogura Y
Ophthalmic Surg Lasers Imaging; 2005; 36(2):169-72. PubMed ID: 15792323
[TBL] [Abstract][Full Text] [Related]
16. Increased incidence of sterile endophthalmitis after intravitreal triamcinolone acetonide in spring 2006.
Stepien KE; Eaton AM; Jaffe GJ; Davis JL; Raja J; Feuer W
Retina; 2009 Feb; 29(2):207-13. PubMed ID: 19050670
[TBL] [Abstract][Full Text] [Related]
17. Effect of intravitreal injections and volume changes on intraocular pressure: clinical results and biomechanical model.
Kotliar K; Maier M; Bauer S; Feucht N; Lohmann C; Lanzl I
Acta Ophthalmol Scand; 2007 Nov; 85(7):777-81. PubMed ID: 17573861
[TBL] [Abstract][Full Text] [Related]
18. Vitreous concentration of triamcinolone acetonide after a single transseptal depot injection.
Silva PS; Singh RJ; Bakri SJ; Lising RS; Santiago DE; Uy HS
Ocul Immunol Inflamm; 2009; 17(3):216-20. PubMed ID: 19585367
[TBL] [Abstract][Full Text] [Related]
19. Examination of purification methods and development of intravitreal injection of triamcinolone acetonide.
Oishi M; Maeda S; Nakamura A; Kurokawa N; Ohguro N; Tano Y
Jpn J Ophthalmol; 2005; 49(5):384-7. PubMed ID: 16187038
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal triamcinolone acetonide injection for the treatment of posterior uveitis.
Tay-Kearney ML
Ocul Immunol Inflamm; 2006 Aug; 14(4):201-2. PubMed ID: 16911980
[No Abstract] [Full Text] [Related]
[Next] [New Search]
